ATE290876T1 - Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil - Google Patents
Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteilInfo
- Publication number
- ATE290876T1 ATE290876T1 AT00201627T AT00201627T ATE290876T1 AT E290876 T1 ATE290876 T1 AT E290876T1 AT 00201627 T AT00201627 T AT 00201627T AT 00201627 T AT00201627 T AT 00201627T AT E290876 T1 ATE290876 T1 AT E290876T1
- Authority
- AT
- Austria
- Prior art keywords
- propylene glycol
- cyclosprin
- pharmaceutical composition
- active ingredient
- composition containing
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 12
- -1 C12 fatty acids Chemical class 0.000 abstract 4
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical group CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 3
- 229930105110 Cyclosporin A Natural products 0.000 abstract 3
- 108010036949 Cyclosporine Proteins 0.000 abstract 3
- 229960001265 ciclosporin Drugs 0.000 abstract 3
- 229930182912 cyclosporin Natural products 0.000 abstract 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 2
- 239000004359 castor oil Substances 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000012052 hydrophilic carrier Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201627A EP1151755B1 (de) | 2000-05-04 | 2000-05-04 | Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290876T1 true ATE290876T1 (de) | 2005-04-15 |
Family
ID=8171456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00201627T ATE290876T1 (de) | 2000-05-04 | 2000-05-04 | Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1151755B1 (de) |
| AT (1) | ATE290876T1 (de) |
| DE (1) | DE60018715T2 (de) |
| DK (1) | DK1151755T3 (de) |
| ES (1) | ES2235765T3 (de) |
| PT (1) | PT1151755E (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2116228A1 (de) | 2001-10-19 | 2009-11-11 | Isotechnika Inc. | Neuartige Cyclosporinanalog-Mikroemulsionspräkonzentrate |
| WO2005037250A1 (en) * | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| WO2005037251A1 (en) * | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| DK1748759T3 (da) * | 2004-04-27 | 2013-04-22 | Javeri Indu | Fremgangsmåder til at forøge hydrofobe forbindelsers opløselighed i vand af ved micellære dispersioner |
| US7345093B2 (en) | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US7659310B2 (en) | 2004-04-27 | 2010-02-09 | Formatech, Inc. | Methods of enhancing solubility of agents |
| JP2010508357A (ja) * | 2006-10-31 | 2010-03-18 | ワイス エルエルシー | ホスホリパーゼ酵素阻害剤の処方 |
| US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
| WO2011038068A1 (en) | 2009-09-23 | 2011-03-31 | Formatech, Inc. | Methods for the preparation of liposomes |
| ITMI20111050A1 (it) * | 2011-06-10 | 2012-12-11 | Sevecom Spa | Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali. |
| MA40433A (fr) | 2014-07-21 | 2017-06-14 | Sevecom Spa | Émulsion en poudre pour aliments pour animaux |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
| PT982035E (pt) * | 1998-08-18 | 2004-08-31 | Panacea Biotec Ltd | Composicao de ciclosporina compreendendo um veiculo hidrofilo |
-
2000
- 2000-05-04 AT AT00201627T patent/ATE290876T1/de not_active IP Right Cessation
- 2000-05-04 PT PT00201627T patent/PT1151755E/pt unknown
- 2000-05-04 DE DE60018715T patent/DE60018715T2/de not_active Expired - Fee Related
- 2000-05-04 EP EP00201627A patent/EP1151755B1/de not_active Expired - Lifetime
- 2000-05-04 ES ES00201627T patent/ES2235765T3/es not_active Expired - Lifetime
- 2000-05-04 DK DK00201627T patent/DK1151755T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2235765T3 (es) | 2005-07-16 |
| PT1151755E (pt) | 2005-05-31 |
| DE60018715T2 (de) | 2006-04-27 |
| EP1151755A1 (de) | 2001-11-07 |
| EP1151755B1 (de) | 2005-03-16 |
| DE60018715D1 (de) | 2005-04-21 |
| DK1151755T3 (da) | 2005-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921409D1 (de) | Cyclosporin enthaltende Zusammensetzungen | |
| DE60018715D1 (de) | Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil | |
| EE200300235A (et) | Ravimpreparaat, milles aktiivne ingredient on ühtlaselt dispergeeritud abiainete alussegus, ning seda sisaldav doseerimisvorm | |
| AP2000001943A0 (en) | Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent. | |
| ES2186715T3 (es) | Uso de un tensioactivo lipofilico en una composicion farmaceutica. | |
| MX9800188A (es) | Composiciones topicas estables. | |
| CA2166388A1 (en) | Antifungal composition for external use retentive in stratum corneum | |
| TW200716113A (en) | Matrix for sustained, invariant and independent release of active compounds | |
| CO5140102A1 (es) | Formulacion farmaceutica en forma de pasta semisolida estabilizada para administracion oral que comprende omeprazol, de dos a cuatro agentes basificantes, un agente espesante y un vehiculo aceitoso hidrofobico | |
| WO2003032933A8 (de) | Kosmetische und/oder pharmazeutische rückfettende zubereitungen | |
| NZ512287A (en) | Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester | |
| AU6087699A (en) | Agent for repelling and inactivating pathogenic organisms of plants | |
| UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| AU692801B2 (en) | Pharmaceutical compositions comprising a staurosporine as active ingredient. | |
| DE60135927D1 (en) | Nd | |
| EP1043015A3 (de) | Homogene flüssige Duftstoff-Zusammensetzung auf Basis von flüchtigen Silikonen | |
| ATE279199T1 (de) | Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten | |
| IT1250672B (it) | Formulazioni orali di ubidecarenone in soluzione acquosa | |
| SE0302924D0 (sv) | Pharmaceutical composition having a cationic excipient | |
| HK1044485A1 (zh) | 药物载体配方 | |
| RU97113599A (ru) | Ранозаживляющая композиция "леста" | |
| RU2002116010A (ru) | Антисептическое средство "АХДЕЗ 3000" | |
| RU2000113775A (ru) | Препарат для профилактики и лечения эндометрита | |
| AR034494A1 (es) | Composiciones para el tratamiento del cabello. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1151755 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |